GSK settles another Zantac lawsuit in California Ruchika Sharma1 Feb 2024 4:15 PM ISTCalifornia: GSK said on Thursday it had agreed to settle another lawsuit in California that alleged its discontinued heartburn drug Zantac...
GSK Omjjara gets European Commission marketing authorisation Ruchika Sharma29 Jan 2024 4:45 PM ISTLondon: GSK plc has announced the European Commission has granted marketing authorisation for Omjjara (momelotinib), a once-a-day, oral JAK1/JAK2...
GSK raises USD 1.24 billion from latest Haleon stake sale Ruchika Sharma17 Jan 2024 5:38 PM ISTNew Delhi: GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business...
GSK to acquire Aiolos Bio for USD 1 billion Ruchika Sharma13 Jan 2024 10:00 AM ISTLondon: GSK plc and Aiolos Bio, Inc. have announced that they have entered into an agreement under which GSK will acquire Aiolos, a...
GSK Nucala approved in China for use in severe asthma with eosinophilic phenotype Ruchika Sharma12 Jan 2024 11:35 AM ISTLondon: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), as an add-on...
GSK enters exclusive license agreement with Hansoh for HS-20093 Ruchika Sharma24 Dec 2023 10:00 AM ISTLondon: GSK plc and Hansoh Pharma, a Chinese biopharmaceutical company have announced that they have entered into an exclusive license agreement...
Jemperli plus Zejula combo significantly improved progression-free survival in primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma20 Dec 2023 2:30 PM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
Japan accepts GSK Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk Ruchika Sharma14 Dec 2023 10:00 AM ISTLondon: GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a regulatory application to extend...
GSK gets European Commission marketing authorisation for Jemperli, chemotherapy combo for endometrial cancer Ruchika Sharma13 Dec 2023 3:30 PM ISTLondon: GSK plc has announced the European Commission (EC) has granted marketing authorisation for Jemperli (dostarlimab) in combination with...
GSK declares positive results from phase III trial for Blenrep in relapsed/ refractory multiple myeloma Ruchika Sharma28 Nov 2023 12:30 PM ISTLondon: GSK plc has announced positive headline results from a planned interim efficacy analysis of the DREAMM-7 head-to-head phase III trial...
GSK to start phase 3 trials of low-carbon Ventolin inhaler in 2024 Ruchika Sharma23 Nov 2023 3:26 PM ISTLondon: GSK plc has announced it will start Phase III trials of a low carbon version of its metered dose inhaler (MDI), Ventolin (salbutamol), using a...
GSK gets positive EMA Committee opinion recommending Momelotinib for myelofibrosis patients with anaemia Ruchika Sharma15 Nov 2023 2:30 PM ISTLondon: GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...
